A Multicenter, Randomized, Double Blind, Parallel-Group Study Comparing the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1%, to Clonidine Hydrochloride Gel Comparator in the Management of Painful Diabetic Neuropathy
Phase of Trial: Phase II
Latest Information Update: 22 Sep 2017
At a glance
- Drugs Clonidine (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- Sponsors BioDelivery Sciences International
- 13 Dec 2016 Results published in the BioDelivery Sciences International Media Release
- 13 Dec 2016 Primary endpoint has not been met. (Reduction in numerical pain rating scores (NPRS) from baseline compared to Week 12), as reported in a BioDelivery Sciences International media release.
- 30 Nov 2016 Status changed from active, no longer recruiting to completed.